Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype

American Journal of Gastroenterology

Volumn 101, Issue 1, 2006, Pages 99-106

  Brand, Stephan ^a   Hofbauer, Katrin ^a   Dambacher, Julia ^a   Schnitzler, Fabian ^a   Staudinger, Tanja ^a   Pfennig, Simone ^a   Seiderer, Julia ^a   Tillack, Cornelia ^a   Konrad, Astrid ^a   Göke, Burkhard ^a   Ochsenkühn, Thomas ^a   Lohse, Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; FRACTALKINE; GENOMIC DNA; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE (C X3 C MOTIF) LIGAND 1; CHEMOKINE (C-X3-C MOTIF) LIGAND 1; CX3C CHEMOKINE; CX3CR1 PROTEIN, HUMAN; CYTOKINE RECEPTOR; MEMBRANE PROTEIN; V28 RECEPTOR; VIRUS RECEPTOR;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE LOCATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTESTINE STENOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UPREGULATION; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; INTESTINE OBSTRUCTION; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINES, CX3C; CONFIDENCE INTERVALS; CROHN DISEASE; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTESTINAL OBSTRUCTION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, HIV; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33644862062     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00361.x     Document Type: Article

References (35)

1. Yang SK Eckmann L Panja A et al Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells Gastroenterology 1997 113 1214 23
2. Dwinell MB Eckmann L Leopard JD et al Chemokine receptor expression by human intestinal epithelial cells Gastroenterology 1999 117 359 67
3. Brand S Sakaguchi T Gu X et al Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells Gastroenterology 2002 122 166 77
4. Matloubian M David A Engel S et al A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo Nat Immunol 2000 1 298 304
5. Wilbanks A Zondlo SC Murphy K et al Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines J Immunol 2001 166 5145 54
6. Bazan JF Bacon KB Hardiman G et al A new class of membrane-bound chemokine with a CX3C motif Nature 1997 385 640 4
7. Imai T Hieshima K Haskell C et al Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion Cell 1997 91 521 30
8. Muehlhoefer A Saubermann LJ Gu X et al Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa J Immunol 2000 164 3368 76
9. Ahn SY Cho CH Park KG et al Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression Am J Pathol 2004 164 1663 72
10. Chapman GA Moores KE Gohil J et al The role of fractalkine in the recruitment of monocytes to the endothelium Eur J Pharmacol 2000 392 189 95
11. Lucas AD Chadwick N Warren BF et al The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo Am J Pathol 2001 158 855 66
12. Combadiere C Salzwedel K Smith ED et al Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1 J Biol Chem 1998 273 23799 804
13. Niess JH Brand S Gu X et al CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance Science 2005 307 254 8
14. Reeves JD McKnight A Potempa S et al CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry Virology 1997 231 130 4
15. Faure S Meyer L Costagliola D et al Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1 Science 2000 287 2274 7
16. Moatti D Faure S Fumeron F et al Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease Blood 2001 97 1925 8
17. Harrison JK Jiang Y Wees EA et al Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart J Leukoc Biol 1999 66 937 44
18. Ruth JH Volin MV Haines GK 3rd. et al Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis Arthritis Rheum 2001 44 1568 81
19. Efsen E Grappone C DeFranco RM et al Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans J Hepatol 2002 37 39 47
20. Gasche C Scholmerich J Brynskov J et al A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 Inflamm Bowel Dis 2000 6 8 15
21. McDermott DH Halcox JP Schenke WH et al Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis Circ Res 2001 89 401 7
22. Abreu MT Taylor KD Lin YC et al Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease Gastroenterology 2002 123 679 88
23. Radlmayr M Torok HP Martin K et al The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease Gastroenterology 2002 122 2091 2
24. Hampe J Grebe J Nikolaus S et al Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: A cohort study Lancet 2002 359 1661 5
25. Schnitzler F Lohse P Seiderer J et al Homozygosity for the 3020insC mutation of the CARD15/NOD2 gene is a strong predictor for a very severe subtype of Crohn's disease characterized by long-segment bulky fibrostenoses of the terminal ileum (abstract) Gut 2004 53 A142
26. Ogura Y Bonen DK Inohara N et al A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 2001 411 603 6
27. Hugot JP Chamaillard M Zouali H et al Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 2001 411 599 603
28. Hampe J Cuthbert A Croucher PJ et al Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations Lancet 2001 357 1925 8
29. Inohara N Ogura Y Fontalba A et al Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease J Biol Chem 2003 278 5509 12
30. Girardin SE Boneca IG Viala J et al Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection J Biol Chem 2003 278 8869 72
31. Daoudi M Lavergne E Garin A et al Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1 J Biol Chem 2004 279 19649 57
32. Assmann SF Pocock SJ Enos LE et al Subgroup analysis and other (mis)uses of baseline data in clinical trials Lancet 2000 355 1064 9
33. Perneger TV What's wrong with Bonferroni adjustments BMJ 1998 316 1236 8
34. Perneger TV Adjusting for multiple testing in studies is less important than other concerns BMJ 1999 318 1288
35. Sabate JM Ameziane N Lamoril J et al V249I polymorphism of CX3CR1 gene in patients with Crohn's disease is associated with a stenotic form of the disease (abstract) Gut 2004 53 Suppl VI A144